Plunkett Consulting is pleased to announce the addition of Sarah Henderson to the Regulatory team.
Sarah has recently returned to Australia after period working in the United Kingdom for Actavis (recently acquired by Teva Pharmaceutical Industries). There she gained experience and knowledge in working in the European regulatory field (including in National and Mutual Recognition/Decentralised Procedures) and interacting with a number of the key regulatory agencies, such as MHRA, BfArM and ANSM. During her time in Europe she also gained her Regulatory Affairs Certification (RAC) in European Regulatory Affairs.
Prior to this, Sarah spent several years working for CSL in Australia, where she worked on a variety of regulatory projects in prescription medicines, from New Chemical entity (NCE) submissions through to lifecycle regulatory activities. Her time at CSL also involved growing and maintaining relationships with key European partners.
Complementary to her experience in regulatory affairs, Sarah also spent several years working for IP Australia, (the National Patent office) where she worked on assessing and administrating pharmaceutical patents.
Sarah holds a Bachelor of Arts/Bachelor of Science (Hons.) majoring in Biochemistry from the University of Melbourne.